comparemela.com

Latest Breaking News On - Ivyp altomare - Page 1 : comparemela.com

SB3 Proves Comparable Cardiovascular Safety to Reference Trastuzumab

Data from a secondary analysis of a randomized controlled trial provide an overview of the cardiovascular safety of trastuzumab biosimilar SB3 compared to the reference agent.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.